Literature DB >> 11525351

Antimicrobial susceptibility of Mycobacterium marinum determined by E-test and agar dilution.

J Werngren1, B Olsson-Liljequist, L Gezelius, S E Hoffner.   

Abstract

Mycobacterium marinum is recognized as a cutaneous pathogen requiring antibiotic treatment. We compared the E-test with a reference agar dilution method for susceptibility testing of M. marinum to amikacin, ciprofloxacin, clarithromycin, doxycycline, rifampicin, trimethoprim-sulfamethoxazole and ethambutol. MICs obtained after 6 d showed agreement between the E-test and agar dilution within +/- 2 dilutions in 95% of all cases for amikacin, ciprofloxacin, doxycycline and rifampicin. Inhibitory concentrations of trimethoprim-sulfamethoxazole were difficult to define using the E-test because of gradually decreased growth in the presence of increasing concentrations. For clarithromycin, results were generally 1-3 dilution steps lower with the E-test and for ethambutol they were often > 3 dilution steps lower. These differences always appeared in the low MIC range and did not affect the categorization of the strains as susceptible to these 2 antimicrobial agents. All strains were interpreted as susceptible to all tested antibiotics, except for doxycycline, according to recommended breakpoints. Overall, our results suggest that the E-test can be considered an alternative for susceptibility testing of certain antibacterial agents against M. marinum.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11525351     DOI: 10.1080/00365540110026773

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  3 in total

1.  Susceptibilities of Mycobacterium marinum to gatifloxacin, gemifloxacin, levofloxacin, linezolid, moxifloxacin, telithromycin, and quinupristin-dalfopristin (Synercid) compared to its susceptibilities to reference macrolides and quinolones.

Authors:  Martin Bråbäck; Kristian Riesbeck; Arne Forsgren
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

2.  Evaluation of the SLOMYCO Sensititre(®) panel for testing the antimicrobial susceptibility of Mycobacterium marinum isolates.

Authors:  Marion Chazel; Hélène Marchandin; Nicolas Keck; Dominique Terru; Christian Carrière; Michael Ponsoda; Véronique Jacomo; Gilles Panteix; Nicolas Bouzinbi; Anne-Laure Bañuls; Marc Choisy; Jérôme Solassol; Alexandra Aubry; Sylvain Godreuil
Journal:  Ann Clin Microbiol Antimicrob       Date:  2016-05-06       Impact factor: 3.944

Review 3.  Evolution of Antibacterial Drug Screening Methods: Current Prospects for Mycobacteria.

Authors:  Clara M Bento; Maria Salomé Gomes; Tânia Silva
Journal:  Microorganisms       Date:  2021-12-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.